Myasthenia gravis associated with human T-cell lymphotropic virus type III infection. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Myasthenia gravis associated with human T-cell lymphotropic virus type III infection.

Pediatr Neurol. 1987 Jul-Aug;3(4):238-9. Unique Identifier : AIDSLINE MED/89206903
Wessel HB; Zitelli BJ; Department of Pediatrics, Children's Hospital of Pittsburgh,; University of Pittsburgh School of Medicine, Pennsylvania 15213.

Abstract: A 15-year-old boy is described with myasthenia gravis, hemophilia A, positive HTLV-III serology, antithyroglobulin and antimicrosomal antibodies, and laboratory evidence of altered cell-mediated immunity. Treatment with pyridostigmine produced dramatic clinical improvement. The results of this patient raise the possibility of myasthenia gravis as the sole or presenting clinical manifestation of infection with HTLV-III.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adolescence Case Report Hemophilia/COMPLICATIONS Human HIV/*IMMUNOLOGY HIV Antibodies/*ANALYSIS Male Myasthenia Gravis/DRUG THERAPY/*ETIOLOGY Pyridostigmine Bromide/THERAPEUTIC USE JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDcomplicationsadolescencecasereporthemophilia/complicationshumanhiv/KWDimmunologyhivantibodies/KWDanalysismalemyastheniagravis/drugtherapy/KWDetiologypyridostigminebromide/therapeuticusejournalarticle
890830
M8980819

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .